Jasper Therapeutics, Inc. · NASDAQ:JSPR
Qiming U.S. Healthcare Fund II, L.P.'s stake in Jasper Therapeutics, Inc. fell to 3.30% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Qiming U.S. Healthcare Fund II, L.P.'s stake in Jasper Therapeutics, Inc. fell to 3.30%, 928,964 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 3.30%
- Shares
- 928,964
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Qiming U.S. Healthcare Fund II, L.P. | 3.30% | 928,964 |
| Qiming U.S. Healthcare GP II, LLC | 3.30% | 928,964 |
| Mark McDade | 3.30% | 928,964 |
| GARY E RIESCHEL | 3.30% | 928,964 |
Source
Related
- Jasper Therapeutics, Inc.
- Qiming U.S. Healthcare Fund II, L.P.
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026